CACrown ArchivesThe cinema collection
EN/FR
Search
Menu
Research dossier · General Reference

Desloratadine/pseudoephedrine

medication used for the treatment of seasonal allergic rhinitis

Cross-disciplinary reference desk with index cards, atlas, dictionary and catalogue
General referenceInterpretive dossier study · Crown Archives visual atlas
Record originEnglish Wikipedia
Text licenseCC BY-SA 4.0
Source revisionMay 29, 2025
Entity authorityQ96376272 ↗
Source-derived summary

Desloratadine/pseudoephedrine, sold under the brand name Clarinex-D among others, is a medication used for the treatment of seasonal allergic rhinitis.

Desloratadine/pseudoephedrine was approved for use in the United States in 2005 and in the European Union in July 2007.

Medical uses

Desloratadine/pseudoephedrine is indicated for the symptomatic treatment of seasonal allergic rhinitis when accompanied by nasal congestion.

References

Further reading

Anolik R (June 2009). "Desloratadine and pseudoephedrine combination therapy as a comprehensive treatment for allergic rhinitis and nasal congestion". Expert Opin Drug Metab Toxicol. 5 (6): 683–94. doi:10.1517/17425250902980187. PMID 19473112. S2CID 22633518.

Editorial summary

The public source identifies “Desloratadine/pseudoephedrine” as medication used for the treatment of seasonal allergic rhinitis. This brief keeps that definition visible, then builds a research path around Desloratadine, pseudoephedrine and medication.

Editorial reviewA dependable orientation record for establishing vocabulary, names and a first evidence trail. The current lead gives the account dated anchors—2005, 2007, 2009, 1517—that can be checked directly. The selected authority fields contribute no independent date. Its value is orientation rather than verdict, with Desloratadine, pseudoephedrine and medication providing the first useful test.
Editorial analysis

Why this record matters

A short description can identify a subject without explaining its stakes. For “Desloratadine/pseudoephedrine”, the useful work is to connect “medication used for the treatment of seasonal allergic rhinitis” to the records capable of establishing context and consequence.

Evidence profile

The citation trail is more important than the brevity of the summary: it shows where individual claims can be examined in context. The source revision retrieved here is dated May 29, 2025. The linked authority identifier is Q96376272. The first chronological checks are 2005, 2007, 2009 and 1517.

Critical limits

The absence of detail may reflect summary conventions rather than a lack of surviving documentation. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.

How to read it

Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.

Best used for
  • Subject orientation
  • Search vocabulary
  • Locating named sources
Verify next

The closest primary source, responsible institution and strongest cited specialist reference.

Three-step research path

  1. Establish the record: confirm the title “Desloratadine/pseudoephedrine”, its source revision and the description used here.
  2. Expand the search: follow Desloratadine/pseudoephedrine primary sources, Desloratadine/pseudoephedrine archive and Desloratadine research across catalogues and specialist indexes.
  3. Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.

Questions for further research

  1. Which source most directly establishes the central claim about “Desloratadine/pseudoephedrine”?
  2. Which institution is responsible for the underlying evidence?
  3. What terminology or title could unlock a more precise catalogue search?
Subject index

Search terms from this dossier

Source & attribution

This entry incorporates text from “Desloratadine/pseudoephedrine” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.